The National Research Council of Canada (NRC) and CCRM announced today that the not-for-profit corporation Biologics Manufacturing Centre (BMC) Inc. has officially assumed responsibility for the operations of the Biologics Manufacturing Centre.
This transition of governance is in accordance with the Government of Canada's announcement in August 2020 that Canada's new biomanufacturing facility would be operated through a public-private partnership.
CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies, was selected following a nation-wide open call for proposals to work with the NRC to jointly set up the not-for-profit corporation to operate the Biologics Manufacturing Centre.
The NRC will continue to own the infrastructure, on behalf of the Government of Canada, and act as lessor of the building and equipment to Biologics Manufacturing Centre (BMC) Inc. under the new governance structure. The NRC will also provide annual funding to ensure the facility is maintained in a good manufacturing practices readiness state and is prepared to respond to future public health emergencies.
